 |
|
 |
The staphylococci are perhaps the preeminent
opportunistic pathogens in that they exist as commensal inhabitants of a
significant proportion of the healthy human population yet retain the capacity
to cause serious and even life-threatening disease. This is particularly true of
Staphylococcus aureus, which
is capable of producing a diverse array of virulence factors and causing a
correspondingly diverse array of infections. At the same time, the coagulase-negative
species S. epidermidis is of
increasing medical significance owing largely to its remarkable capacity to
colonize indwelling medical devices. The continuing emergence of antibiotic
resistant strains of both species is a major concern; indeed, recent years have
seen the appearance of vancomycin-resistant
S. aureus (VRSA) and even strains
that are resistant to new drugs (e.g. linezolid, daptomycin) introduced in
response to the appearance of VRSA. This emphasizes the urgent need to identify
new targets for anti-staphylococcal therapy, and identification of such targets
is a primary focus of our research. We are particularly interested in those
virulence factors that are most relevant to musculoskeletal infection, and we
have placed a specific emphasis on biofilm formation because we believe biofilms
play a particularly important role in many of these infections both in terms of
native tissues (bone and cartilage) and indwelling medical devices (catheters,
orthopaedic implants). This biofilm, which consists of multiple layers of
bacterial cells encased in an extracellular matrix, not only protects bacteria
from host defenses but also impedes delivery of at least some antibiotics.
Perhaps more importantly, the phenotype of biofilm-associated bacteria confers
intrinsic resistance to specific antimicrobial agents at least within a subset
of the population of bacterial cells. For instance, such bacteria grow very
slowly if at all, and this limits the efficacy of antibiotics that target cell
wall biosynthesis (e.g. the beta-lactams). Based on this, we are actively
investigating the mechanisms of biofilm formation in
S. aureus and the nature of the
adaptive response to the sessile lifestyle.
Owing at least in part to formation of a biofilm,
many staphylococcal musculoskeletal infections, including those associated with
indwelling medical devices, cannot be resolved without surgical intervention. It
is important to emphasize that, while antibiotic resistance among the
staphylococci is a primary concern, the recalcitrance of these infections is not
a function of acquired resistance. Indeed, in many cases, the offending bacteria
are found to be fully susceptible once they are removed from the biofilm and
tested under in vitro
conditions. Based on this, we believe it is also important to develop better
ways to diagnosis infection in a timely manner (i.e. before the formation of
necrotic bone and/or a biofilm). Indeed, we believe early detection would
greatly facilitate treatment, possibly to the point that surgical debridement
would become an option rather than an imperative. Based on this, we are
investigating noninvasive imaging methods (e.g. FDG-PET) for the diagnosis and
management of staphylococcal musculoskeletal infection. We also believe that a
more effective means of antibiotic delivery would facilitate the efficacy of
both existing and newly developed antimicrobial agents. To address this issue,
we are evaluating the efficacy of different antimicrobial agents in the specific
context of musculoskeletal and biofilm-associated infection as well as novel
methods of delivering those antibiotics to the site of infection. Importantly,
while our experiments focus on the staphylococci, the methods we develop will be
directly applicable to other bacterial pathogens that cause similar infections.
These experiments will also compliment our ongoing studies focusing on the
staphylococcal virulence factors that are most relevant in the pathogenesis of
musculoskeletal and biofilm-associated infection.
Questions about this page? Send us an email.
This site created and maintained by Allen Gies and UAMS Media Services
All contents copyright 2007
|
 |